⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ADCT News
ADC Therapeutics SA
ADC Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference
prnewswire.com
ADCT
Global CD70-Targeting Therapies Market Report 2026 - Highlights Clinical Innovation, Pipeline Trends and Commercial Opportunities
globenewswire.com
ALLO
CRSP
JNJ
PFE
ADCT
REGN
MRNA
BMY
GILD
AMGN
BIIB
AZN
NVS
LLY
ABBV
Form 8-K
sec.gov
ADCT
ADC Therapeutics Reports Second Quarter 2026 Financial Results and Provides Operational Updates
prnewswire.com
ADCT
Form 8-K
sec.gov
ADCT
ADC Therapeutics Announces New Employee Inducement Grant
prnewswire.com
ADCT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT
accessnewswire.com
ADCT
ADC Therapeutics Announces Completion of Enrollment in LOTIS-7 Phase 1b ZYNLONTA® Combination Trial
prnewswire.com
ADCT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT
accessnewswire.com
ADCT
Harbour BioMed Appoints Dr. Lloyd Klickstein as Scientific Advisor for Immunology
prnewswire.com
ADCT
BTAI
RLAY